The vaccine that the pharmacist AstraZeneca and the University of Oxford develop against COVID-19 showed “Promising results” having stimulated the desired response of the immune system, reported the British press a week ago. The World Health Organization (WHO) stated in late June that the vaccine against COVID-19 developed by the association was the most advanced so far.
The company, based in UK, expect to produce between 300 and 400 million doses from the end of this year. The effects they caught the attention of governments in the world. Britain already has an agreement with this group to provide 100 million doses of the vaccine against coronavirus what is on the phase 3 from investigation.
The richer countries of the planet are guaranteeing their future. They pay for vaccines that don’t exist, yet. They finance laboratories. They make alliances with pharmaceutical companies that are in phase 1 or phase 3 of developing. But the only statement about the possible unit cost from injection it was given by the general director of AstraZeneca, Pascal Soriot, to the chain of news European RTL.
“Our goal is to supply the vaccine to the whole world, we have a goal that is also to do it without benefit, that is, we will deliver the vaccine at cost price throughout the world. At cost price it will be around 2.5 euros, ”he said in an interview.
Based on Soriot’s statements, the cost of the vaccine in Mexico could rise to 64.36 pesos, taking into account the exchange rate of 25.7477 pesos for each euro, according to Banco de México estimates.
Initially the pharmacist would not have benefits for the production of the drug.
In addition, the director assured that they are looking to have results from phase 3 of the study for the fall. “We think that we will be able to supply the COVID-19 vaccine at the end of the year at the latest,” he said. “We work in accordance with the regulators, we exchange daily data so that the evaluation is done quickly. We manufacture at the same time that we do clinical trials, thus we save time, “he said.
Brazil also committed to AstraZeneca to obtain the vaccine, with an outlay of $ 288 million for the first 100 million doses and for the transfer of technology to produce a vaccine. In a first phase of the agreement, Brazil will pay $ 127 million for 30.4 million doses of the vaccine that it will receive in two batches, one in December 2020 and the other until January 15, 2021.
-With information from AP, EFE and RT
Video: La Jornada – In Mexico there are 40 thousand deaths a year from diseases associated with the consumption of sugary drinks: Ssa (La Jornada)
- La Jornada – They seek to detect coronaviruses in wastewater in Querétaro
Dr. Germán Buitrón, from the Engineering Institute at the Juriquilla Academic Unit in Querétaro belonging to UNAM, has a proposal to face the Covid-19 pandemic, which will allow him to anticipate contagion outbreaks and have advance information on the behavior of the virus.
- La Jornada – Weather Forecast July 21, 2020
A low pressure channel that will extend from the northwest to the center of the country, in interaction with superior atmospheric instability and the entry of humidity from the Gulf of Mexico and the Pacific Ocean, will cause very heavy punctual rains in Guanajuato, Guerrero, Michoacán, Morelos , Puebla, Sinaloa, Sonora and the Valley of Mexico.
- La Jornada – National strike in the US against racism and inequality
Thousands of people in more than two dozen cities in the United States on Monday stopped work in protest against racism and economic inequality, which have worsened during the coronavirus pandemic.